Breast Cancer

BreastPalazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerPrincipal Investigator: Jing Du
Breast, Ovary, Phase IPhase 1/2A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients with Advanced Solid Tumors
Breast, Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Lung, Other Urinary, Phase I, ThyroidFirst-In-Human, Open-Label, Dose Escalation and Expansion Trial to Evaluate the Safety, Pharmacokinetics and Efficacy of GEN1106 in Participants With Solid Tumors
BreastA Randomized, Phase III Trial of Pre-Operative Window of Endocrine Therapy to Inform Radiation Therapy Decisions in Older Women With Early-Stage Breast Cancer (POWER II)
Breast, Phase IA Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Antitumor Activity of BG-75202, Alone and in Combination With Other Agents in Patients With Advanced Solid Tumors